Your browser doesn't support javascript.
loading
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan.
Liang, Hong; Nian, Xuanxuan; Wu, Junzheng; Liu, Dong; Feng, Lu; Lu, Jia; Peng, Yan; Zhou, Zhijun; Deng, Tao; Liu, Jing; Ji, Deming; Qiu, Ran; Lin, Lianzhen; Zeng, Yan; Xia, Fei; Hu, Yong; Li, Taojing; Duan, Kai; Li, Xinguo; Wang, Zejun; Zhang, Yong; Zhang, Hang; Zhu, Chen; Wang, Shang; Wu, Xiao; Wang, Xiang; Li, Yuwei; Huang, Shihe; Mao, Min; Guo, Huanhuan; Yang, Yunkai; Jia, Rui; Xufang, Jingwei; Wang, Xuewei; Liang, Shuyan; Qiu, Zhixin; Zhang, Juan; Ding, Yaling; Li, Chunyan; Zhang, Jin; Fu, Daoxing; He, Yanlin; Zhou, Dongbo; Li, Cesheng; Zhang, Jiayou; Yu, Ding; Yang, Xiao-Ming.
Affiliation
  • Liang H; Beijing Tiantan Biological Products Co., Ltd., Beijing, China.
  • Nian X; National Engineering Technology Research Center for Combined Vaccines, Wuhan, Hubei, China.
  • Wu J; Wuhan Institute of Biological Products Co., Ltd., Wuhan, Hubei, China.
  • Liu D; Chengdu Rongsheng Pharmaceuticals Co., Ltd., Chengdu, Sichuan, China.
  • Feng L; Beijing Tiantan Biological Products Co., Ltd., Beijing, China.
  • Lu J; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd., Wuhan, Hubei, China.
  • Peng Y; National Engineering Technology Research Center for Combined Vaccines, Wuhan, Hubei, China.
  • Zhou Z; Wuhan Institute of Biological Products Co., Ltd., Wuhan, Hubei, China.
  • Deng T; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd., Wuhan, Hubei, China.
  • Liu J; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd., Wuhan, Hubei, China.
  • Ji D; National Engineering Technology Research Center for Combined Vaccines, Wuhan, Hubei, China.
  • Qiu R; Wuhan Institute of Biological Products Co., Ltd., Wuhan, Hubei, China.
  • Lin L; National Engineering Technology Research Center for Combined Vaccines, Wuhan, Hubei, China.
  • Zeng Y; Wuhan Institute of Biological Products Co., Ltd., Wuhan, Hubei, China.
  • Xia F; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd., Wuhan, Hubei, China.
  • Hu Y; National Engineering Technology Research Center for Combined Vaccines, Wuhan, Hubei, China.
  • Li T; Wuhan Institute of Biological Products Co., Ltd., Wuhan, Hubei, China.
  • Duan K; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd., Wuhan, Hubei, China.
  • Li X; National Engineering Technology Research Center for Combined Vaccines, Wuhan, Hubei, China.
  • Wang Z; Wuhan Institute of Biological Products Co., Ltd., Wuhan, Hubei, China.
  • Zhang Y; National Engineering Technology Research Center for Combined Vaccines, Wuhan, Hubei, China.
  • Zhang H; Wuhan Institute of Biological Products Co., Ltd., Wuhan, Hubei, China.
  • Zhu C; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd., Wuhan, Hubei, China.
  • Wang S; Beijing Tiantan Biological Products Co., Ltd., Beijing, China.
  • Wu X; National Engineering Technology Research Center for Combined Vaccines, Wuhan, Hubei, China.
  • Wang X; Wuhan Institute of Biological Products Co., Ltd., Wuhan, Hubei, China.
  • Li Y; National Engineering Technology Research Center for Combined Vaccines, Wuhan, Hubei, China.
  • Huang S; Wuhan Institute of Biological Products Co., Ltd., Wuhan, Hubei, China.
  • Mao M; National Engineering Technology Research Center for Combined Vaccines, Wuhan, Hubei, China.
  • Guo H; Wuhan Institute of Biological Products Co., Ltd., Wuhan, Hubei, China.
  • Yang Y; Beijing Tiantan Biological Products Co., Ltd., Beijing, China.
  • Jia R; Beijing Tiantan Biological Products Co., Ltd., Beijing, China.
  • Xufang J; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd., Wuhan, Hubei, China.
  • Wang X; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd., Wuhan, Hubei, China.
  • Liang S; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd., Wuhan, Hubei, China.
  • Qiu Z; National Engineering Technology Research Center for Combined Vaccines, Wuhan, Hubei, China.
  • Zhang J; Wuhan Institute of Biological Products Co., Ltd., Wuhan, Hubei, China.
  • Ding Y; National Engineering Technology Research Center for Combined Vaccines, Wuhan, Hubei, China.
  • Li C; Wuhan Institute of Biological Products Co., Ltd., Wuhan, Hubei, China.
  • Zhang J; National Engineering Technology Research Center for Combined Vaccines, Wuhan, Hubei, China.
  • Fu D; Wuhan Institute of Biological Products Co., Ltd., Wuhan, Hubei, China.
  • He Y; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd., Wuhan, Hubei, China.
  • Zhou D; Wuxue Wusheng Plasma Collection Center, Wuxue, Hubei, China.
  • Li C; China National Biotec Group Company Limited, Beijing, China.
  • Zhang J; China National Biotec Group Company Limited, Beijing, China.
  • Yu D; China National Biotec Group Company Limited, Beijing, China.
  • Yang XM; China National Biotec Group Company Limited, Beijing, China.
Cell Discov ; 8(1): 131, 2022 Dec 09.
Article in En | MEDLINE | ID: mdl-36494338
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cell Discov Year: 2022 Document type: Article Affiliation country: China Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cell Discov Year: 2022 Document type: Article Affiliation country: China Country of publication: Reino Unido